# Notebooks on miscellaneous topics


Clinical Protocol:  1812V1567

Protocol Title: A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-selection study of S-600918 in patients with refractory chronic cough
Indian Central Laboratory Project Number 11019XX001

CRO Name: PPD
Sponsor name: Ind Inc. 
Blueprint Version 0.2, Dated 30Sep2019
Based on Clinical Protocol Version 1.0 Dated 04Sep2019
    
The Washington State Department of Health presents this information as a service to the public. True and correct  Indian Central Laboratory Project Number 11019XX001 copies of legal disciplinary actions taken after July 1998 are available on our Provider Credential Search site. These records are considered certified by the Department of Health.
This includes information on health care providers.
Please contact our Customer Service Center at 360-236-4700 for information about actions before July 1998.
The information on this site comes directly from our database and is updated daily at 10:00 a.m.. This data is a primary  Indian Central Laboratory Project Number 11019XX001 source for verification of credentials and is extracted from the primary database at 2:00 a.m. daily.
News releases about disciplinary actions taken against Washington State healthcare providers, agencies or facilities are on the agency's Newsroom webpage.
Disclaimer
The absence of information in the Provider Credential Search system doesn't imply any recommendation, endorsement or guarantee of competence of any healthcare professional. The presence of information Indian Central Laboratory Project Number 11019XX001 in this system doesn't imply a provider isn't competent or qualified to practice. The reader is encouraged to carefully evaluate any information found in this data set.
These data reflect information that has been reported to the California Safe Cosmetics Program (CSCP) in the California Department of Public Health (CDPH). The primary purpose of the CSCP is to collect information on hazardous and potentially hazardous ingredients in cosmetic products sold in California and to make this information available to the public.

These data reflect information that has been reported to the California Safe Cosmetics Program (CSCP) in the California Department of Public Health (CDPH). The primary purpose of the CSCP is to collect information on hazardous and potentially hazardous ingredients in cosmetic products sold in California and to make this information available to the public.
For all cosmetic products sold in California, the California Safe Cosmetics Act (“the Act”) requires the manufacturer, packer, and/or distributor named on the product label to Indian Central Laboratory Project Number 11019XX001 provide to the CSCP a list of all cosmetic products that contain any ingredients known or suspected to cause cancer, birth defects, or other developmental or reproductive harm.
To assist companies with reporting, CDPH has Indian Central Laboratory Project Number 11019XX001 compiled a list of reportable ingredients based on lists and reports available from the authoritative scientific bodies cited in the Act to cause cancer or reproductive harm; it is meant to serve as guidance Indian Central Laboratory Project Number 11019XX001  and is not all-inclusive. Companies with reportable ingredients in their products must submit information to the California Safe Cosmetics Program if the company:
Has annual aggregate sales of cosmetic products of one million dollars or more, and
Has sold cosmetic products in California on or after January 1, 2007.
The data table consists of: label names of cosmetic/personal care products, company/manufacturer names, Indian Central Laboratory Project Number 11019XX001 product brand names, product categories, Chemical Abstracts Service registry numbers (CAS#) of the reported chemical ingredients, names of reported chemical ingredients, the number of reported chemicals for each product, Indian Central Laboratory Project Number 11019XX001and dates of reporting, product discontinuation or reformulation if applicable.
All products containing carcinogens or developmental or Indian Central Laboratory Project Number 11019XX001 reproductive toxicants may not be included due to companies failing to report.

